A Single-arm, Phase II, Multi-center Clinical Trial of Sintilimab During the Perioperative Period in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

Clinical trial NCT07379424 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07379424
Sponsor: chen chao Professor
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

Start date: 2026-01-28
Primary completion: 2027-08-25
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.